Julien Mancini

Prof. Dr. Julien Mancini

Aix Marseille Univ, Inserm, IRD, SESSTIM
+1
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in JACC
Verified
Journal Article
Closed access
LSLudivine Saby
Ludivine Saby
OLOlivia Laas
Olivia Laas
GHGilbert Habib
Gilbert Habib
SCSerge Cammilleri
Serge Cammilleri
JMJulien Mancini
Julien Mancini
FTFranck Thuny
Franck Thuny

1 March 2014 in JACC
Verified
Journal Article
Closed access
LBLaurent Bonello
Laurent Bonello
MLMarc Laine
Marc Laine
NKNathalie Kipson
Nathalie Kipson
JMJulien Mancini
Julien Mancini
OHOlfa Helal
Olfa Helal
RGRegis Guieu
Regis Guieu

1 June 2014 in European Annals of Otorhinolaryngology, Head and Neck Diseases
Verified
Journal Article
Closed access
AFA. Farinetti
A. Farinetti
DGD. Ben Gharbia
D. Ben Gharbia
JMJulien Mancini
Julien Mancini
SRS. Roman
S. Roman
RNR. Nicollas
R. Nicollas
JTJ.-M. Triglia
J.-M. Triglia

1 July 2011 in JACC
Verified
Journal Article
Closed access
LBLaurent Bonello
Laurent Bonello
MPMichel Pansieri
Michel Pansieri
JMJulien Mancini
Julien Mancini
RBRoland Bonello
Roland Bonello
LMLuc Maillard
Luc Maillard
FPFranck Paganelli
Franck Paganelli

26 March 2009 in European Heart Journal
Verified
Journal Article
Open access
PDF file
FTFranck Thuny
Franck Thuny
SBSylvain Beurtheret
Sylvain Beurtheret
JMJulien Mancini
Julien Mancini
VGVlad Gariboldi
Vlad Gariboldi
JCJean-Paul Casalta
Jean-Paul Casalta
GHGilbert Habib
Gilbert Habib
To determine whether the timing of surgery could influence mortality and morbidity in adults with complicated infective endocarditis (IE). In 291 consecutive adults with definite IE who underwent surgery during the active phase, we compared those operated on within the first week of antimicrobial therapy (n = 95) to those operated on later (n = 191). The impact of the timing of surgery on 6-month mortality, relapses, and postoperative valvular dysfunctions (PVD) was analysed using propensity score (PS) analyses. After stratification of the cohort into quintiles based on the PS, ≤1st week surgery was associated with a trend of decrease in 6-month mortality in the quintile of patients with the most likelihood of undergoing this early surgical management [quintile 5: 11% vs. 33%, odds ratio (OR) = 0.18, 95% CI (confidence interval) 0.04–0.83, P = 0.03]. Patients of this subgroup were younger, were more likely to have Staphylococcus aureus infections, congestive heart failure, and larger vegetations. Besides, ≤1st week surgery was associated with an increased number of relapses or PVD (16% vs. 4%, adjusted OR = 2.9, 95% CI 0.99–8.40, P = 0.05). Surgery performed very early may improve survival in patients with the most severe complicated IE. However, a greater risk of relapses and PVD should be expected when surgery is performed very early.

6 June 2014 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
GTGuillemette Thomas
Guillemette Thomas
JMJulien Mancini
Julien Mancini
NJNoemie Jourde-Chiche
Noemie Jourde-Chiche
GSGabrielle Sarlon
Gabrielle Sarlon
ZAZahir Amoura
Zahir Amoura
LCLaurent Chiche
Laurent Chiche
Objective: To assess the mortality profile of systemic lupus erythematosus (SLE) patients in France using multiple‐cause‐of‐death analysis.Methods: Data were collected between 2000 and 2009 in the French Epidemiological Center for the Medical Causes of Death database, and death certificates issued upon the death of an adult for whom SLE was an underlying cause of death (UCD) or a non–underlying cause of death (NUCD) were evaluated using multiple‐cause‐of‐death analysis. Sex, age, sex ratio, standardized mortality rates, as well as frequency of the various causes of death were assessed, at both a national and a regional level. For the main causes of death, the observed number of deaths in relation to the expected number of deaths (O:E ratio) (standardized for age and sex) was calculated.Results: During the study period, 1,593 deaths related to SLE were identified. The mean ± SD age at death was 63.5 ± 18.4 years and the sex ratio (female:male) was 3.5. The mean standardized mortality rate was 3.2 per 1 million people (range 2.7–4.1). When SLE was the UCD (n = 637), the main NUCDs were cardiovascular diseases (49.5%), infectious diseases (24.5%), and renal failure (23.2%). When SLE was an NUCD (n = 956), the most common UCDs were cardiovascular diseases (35.7%), neoplasms (13.9%), and infectious diseases (10.3%). The overall O:E ratio was >1 for infectious and cardiovascular diseases and renal failure (especially among people <40 years of age for the latter 2 causes), but was <1 for neoplasms.Conclusion: Cardiovascular disease is the leading cause of death associated with SLE in France.